ABOUT THE EVENT
Date: Wednesday, March 18, 2026 11am–12pm EDT
Event Location: Virtual
Generative AI pilots are becoming the norm across biopharma. Scaling them across the wider enterprise is a different challenge entirely, especially in an industry where patient safety is paramount and regulatory expectations are unforgiving.
In this webinar, we’ll explore how drug developers are unlocking true R&D velocity across the full development lifecycle, from candidate selection to competitive intelligence, by deploying generative AI responsibly and at scale. You’ll also hear how one of the world’s top R&D spenders broke down organizational silos across multidisciplinary teams using validated AI, connected data, and human-in-the-loop workflows built for responsible deployment.
What You’ll Learn:
- Beyond the hype: How generative AI addresses real industry pain points, from candidate validation and selection to go/no-go investment decisions.
- High-impact use cases: Where AI is already delivering measurable value, including novelty assessment, competitive monitoring, and lead compound extraction.
- Responsible AI in action: How to embed traceability, transparency, and human review to minimize hallucination risk and support high-stakes decision-making.
- Case study: A step-by-step playbook for scaling GenAI from proof of concept to secure, compliant deployment ac
